Eric Joel Benjamin,Wendy Ann Dulin,Yanning Lin,Kai Zhuang
申请号：
US16672296
公开号：
US20200138781A1
申请日:
2019.11.01
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides controlled release dosage formulations of compounds having the Formula:or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
